Robb Knie, CEO and President at Hoth Therapeutics, Inc. (HOTH), bought 10,000 shares at $0.39 ($4K) on 2022-09-19, disclosed to the SEC on 2022-09-20.
Open-market purchase of $4k HOTH by CEO and President. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |